Hosted on MSN2mon
How a Duty To Spend Wisely on Worker Benefits Could Loosen PBMs’ Grip on Drug Prices
It edged out a few “transparent PBMs” — a sign, in Wojcik’s view, that CVS at least doesn’t want to be left out as more customers ditch the current PBM business model. With the change ...
Business Insider12d
Pharmacy benefit management unicorn Capital Rx hits $3.5 billion in revenue with a different approach to drug pricing as Congress targets middlemen
With the legacy PBM players under fire, Capital Rx's business is surging. The startup brought in $3.5 billion in revenue last year across its business lines, and CEO AJ Loiacono told Business ...